Over the past 12 months, 0 insiders at Evofem Biosciences, Inc. filed 0 open-market SEC Form 4 transactions on EVFM: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 12, 24 | Yan ZhangCFO | SELL | 104 | $0.04 | $4 |
| Dec 21, 23 | Kim P. KamdarDirector | SELL | 10 | $0.62 | $6 |
| May 27, 22 | Saundra L PelletierChief Executive Officer | BUY | 141.0K | $0.35 | $49K |
| Dec 20, 21 | Justin J. FileChief Financial Officer | BUY | 40.6K | $0.37 | $15K |
| Dec 20, 21 | Alexander A FitzpatrickGeneral Counsel and Secretary | BUY | 25.0K | $0.39 | $10K |
| Dec 20, 21 | Saundra L PelletierChief Executive Officer | BUY | 135.0K | $0.38 | $51K |
Over the past 12 months, insiders at Evofem Biosciences, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on EVFM, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market EVFM insider purchase in our data was $51K by Saundra L Pelletier, Chief Executive Officer, filed on Dec 20, 21.
0 different insiders at Evofem Biosciences, Inc. filed open-market SEC Form 4 transactions on EVFM over the last 12 months.
InsiderTape plots every EVFM insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Evofem Biosciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →